Search

Your search keyword '"Yoojoo Lim"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Yoojoo Lim" Remove constraint Author: "Yoojoo Lim" Search Limiters Full Text Remove constraint Search Limiters: Full Text
48 results on '"Yoojoo Lim"'

Search Results

1. Discontinuation risk from adverse events: immunotherapy alone vs. combined with chemotherapy: a systematic review and network meta-analysis

2. Cancer signature ensemble integrating cfDNA methylation, copy number, and fragmentation facilitates multi-cancer early detection

3. Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes for prediction of prognosis in resected colon cancer

4. Comparison of Tumor Microenvironments between Primary Tumors and Lymph Node Metastases in Head and Neck Squamous Cell Carcinoma and Their Predictive Role in Immune Checkpoint Inhibitor Treatment

5. Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types

6. Artificial intelligence‐powered spatial analysis of tumor‐infiltrating lymphocytes as a biomarker in locally advanced unresectable thymic epithelial neoplasm: A single‐center, retrospective, longitudinal cohort study

7. Predicting the chemotherapeutic response of colorectal cancer liver metastasis using shear-wave elastography

8. 961 Tumor-infiltrating lymphocytes in tumor microenvironment assessed by artificial intelligence powered H&E image analyzer is correlated with immunomodulatory subtype of triple-negative breast cancer

9. Spatial and clonality-resolved 3D cancer genome alterations reveal enhancer-hijacking as a potential prognostic marker for colorectal cancer

10. Circulating tumor DNA sequencing in colorectal cancer patients treated with first-line chemotherapy with anti-EGFR

11. 830 Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes reveals immune-excluded phenotype related to APOBEC signature and clonal evolution of cancer

12. Macrophage migration inhibitory factor promotes resistance to MEK blockade in KRAS mutant colorectal cancer cells

13. FGFR2 amplification is predictive of sensitivity to regorafenib in gastric and colorectal cancers in vitro

14. Clinical Implication of Anti-Angiogenic Effect of Regorafenib in Metastatic Colorectal Cancer.

15. Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in Non-Small Cell Lung Cancer.

16. Practical Utility of Liquid Biopsies for Evaluating Genomic Alterations in Castration-Resistant Prostate Cancer

17. Dynamic changes in longitudinal circulating tumour DNA profile during metastatic colorectal cancer treatment

19. Practical Utility of Liquid Biopsy for Evaluating Genomic Alterations in Castration-Resistant Prostate Cancer

21. Circulating tumor DNA sequencing in colorectal cancer patients treated with first-line chemotherapy with anti-EGFR

22. Abstract 4333: Spatial analysis of tumor-infiltrating lymphocytes in tumor microenvironment as biomarker for immune checkpoint inhibition in biliary tract cancer

23. Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors

25. Abstract 5157: ctDNA change predicts treatment outcome of regorafenib in metastatic colorectal cancer

26. Abstract 5164: cell-free DNA (cfDNA) fragment size as a potential quantitative biomarker for metastatic colorectal cancer (mCRC)

27. FGFR2 amplification is predictive of sensitivity to regorafenib in gastric and colorectal cancers in vitro

28. 830 Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes reveals immune-excluded phenotype related to APOBEC signature and clonal evolution of cancer

29. Korean Cancer Patients’ Awareness of Clinical Trials, Perceptions on the Benefit and Willingness to Participate

30. Macrophage migration inhibitory factor promotes resistance to MEK blockade in KRAS mutant colorectal cancer cells

31. Effect of induction chemotherapy on survival in locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: Single center experience

32. Abstract 36: Application of patients derived organoids as co-clinical model

33. Comparison of Quantitative Methods on FDG PET/CT for Treatment Response Evaluation of Metastatic Colorectal Cancer

34. Acute Lymphoblastic Leukemia in Elderly Patients: A Single Institution's Experience

35. Clinical Implication of Anti-Angiogenic Effect of Regorafenib inMetastatic Colorectal Cancer

36. Abstract 1800: Noninvasive approach to assess metastatic lesion of advanced colorectal cancer by denoised deep target sequencing

37. Abstract 5214: Activation of WNT/b-catenin signaling results in resistance to PI3K/mTOR dual inhibitor in co-existing KRAS and PIK3CA mutant colorectal cancer cells

38. Abstract 3167: MIF-induced stat3 activation promotes resistance to MEK blockade in KRAS mutant colorectal cancer cells

39. Abstract 3972: Total lesion glycolysis (TLG) as an imaging biomarker of regorafenib treatment in metastatic colorectal cancer (mCRC)

40. Korean Cancer Patients’ Awareness of Clinical Trials: Perceptions on the benefit and willingness to participate

41. Incidence, Survival and Prevalence Statistics of Classical Myeloproliferative Neoplasm in Korea

42. Abstract A28: NFATC3-PLA2G15 fusion transcript identified by RNA-sequencing promotes tumor progression in colorectal cancer cells

43. Abstract A2: Clinical implications of anti-angiogenic effect of regorafenib in metastatic colorectal cancer

44. Gefitinib Treatment for Pulmonary Sarcomatoid Carcinoma Driven by an EGFR Mutation: Two Cases

45. Efficacy of Exemestane in Korean Patients with Metastatic Breast Cancer after Failure of Nonsteroidal Aromatase Inhibitors

46. Thrombocytopenia caused by low-dose heparin supplementation of parenteral nutrition solution

47. Abstract 4909: Calcitriol and arsenic trioxide synergistically inhibited proliferation of HL-60 cell line mainly through apoptosis pathway

48. Leukopenia in Patients with Iron Deficiency Anemia

Catalog

Books, media, physical & digital resources